3-Bromo-8-chloroimidazo[1,2-a]pyrazine, 95.0%, 10g

(5-(METHOXYCARBONYL)-1-METHYL-1H-PYRROL-3-YL)BORONIC ACID PINACOL ESTER, 95.0%, 100mg

2,2'-[iminobis(ethane-2,1-diyl)]bis(1H-isoindole-1,3(2H)-dione), 95%, 250mg

1-(4-Methoxy-2-(trifluoromethyl)phenyl)ethanone, 95.0%, 1g

2-(4-Fluorophenyl)-1,3-oxazole-4-carboxylic acid, 95%, 250mg

Tert-butyl (4-(hydroxymethyl)cyclohexyl)carbamate, 98%, 250mg

3-IODOCYCLOPENT-2-ENONE, 95%, 10g

3-(2-Bromoimidazo[2,1-b]thiazol-6-yl)propanoic acid hydrochloride, 95.0%, 5g

(S)-5-Isopropylmorpholin-3-one, 97%, 1g

6-Chloro-3-iodo-1H-pyrrolo[3,2-c]pyridine, 95.0%, 5g

(E)-ethyl 3-(2-chloro-4-(ethylamino)pyrimidin-5-yl)acrylate, 98%, 250mg

N,N-Diisopropylethylamine (DIPEA), 250mL, >=99.5%, for peptide synthesis, glass packaging

6-Bromo-2-methyloxazolo[4,5-b]pyridine, 95.0%, 5g